母亲对乙酰氨基酚摄入与胎儿动脉导管收缩或闭合:病例系列分析
通过结构化文献检索获得12篇文献共25例病例描述,应用WHO-UMC因果关系评估工具分析母亲对乙酰氨基酚摄入与胎儿动脉导管收缩或闭合的关联。结果显示1例不太可能、9例可能、11例很可能、4例确定,认为两者之间可能存在因果关系,提示需开展妊娠期对乙酰氨基酚安全性的药物警戒研究。
要点
- 需开展药物警戒研究量化该事件,将现有发现置于临床背景中。
- 妊娠期及围产期镇痛需权衡替代药物(阿片类、非甾体抗炎药)的副作用。
核心结论
- 母亲对乙酰氨基酚摄入与胎儿动脉导管收缩或闭合之间可能存在因果关系。
研究设计与样本
- 结构化文献检索获得12篇文献共25例病例描述,应用WHO-UMC因果关系评估工具进行评价。
主要发现
- 25例病例中,1例分类为不太可能,9例为可能,11例为很可能,4例为确定。
关键数值与推荐
- WHO-UMC因果关系分类结果:不太可能1例、可能9例、很可能11例、确定4例。
临床怎么用
- 临床应关注妊娠期对乙酰氨基酚使用与胎儿动脉导管收缩或闭合的潜在关联。
- 妊娠期及围产期镇痛选择需权衡替代药物(阿片类、非甾体抗炎药)的副作用。
局限性
- 基于病例系列分析,需药物警戒研究量化事件并置于临床背景中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent case reports describe an association between maternal paracetamol intake and fetal ductus arteriosus constriction or closure. To put these cases into perspective and explore causality, a structured literature search was conducted. The World Health Organization Uppsala Monitoring Centre (WHO-UMC) causality tool was applied to the cases retrieved. The search resulted in 12 papers with 25 case descriptions, of which one case was classified as unlikely, nine as possible, 11 as probable and four as certain. Consequently, we concluded that a causal relationship between maternal paracetamol intake and fetal ductus arteriosus constriction or closure is likely. These findings suggest that pharmacovigilance studies on paracetamol safety during pregnancy are warranted to quantify the event and put the current findings into clinical perspective. Although analgesia during pregnancy and during the peripartum period is of obvious relevance, alternative analgesics such as opioids or other nonsteroidal anti-inflammatory drugs also have side effects.
引用
- Allegaert K, Mian P, Lapillonne A, et al. Maternal paracetamol intake and fetal ductus arteriosus constriction or closure: a case series analysis. Br J Clin Pharmacol. 2018. PMID: 30300944. doi:10.1111/bcp.13778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。